Development of timely controlled-release systems for chronotherapy of propranolol with minimization of the pH effect in the simulated gastrointestinal medium

Lin Wen Lee, Sheng Feng Hung, Hong Liang Lin, Hsiu O. Ho, Ming Thau Sheu

Research output: Contribution to journalArticle

Abstract

A timely controlled release dosage form with minimization of transit time and pH effects of gastrointestinal tract for chronotherapy of propranolol was developed. Ethylcellulose (EC) and Eudragit RS selected as the controlling membrane for drug-layering non-pareil seeds (NP) or extrusion-spheronized pellets incorporated with matrix materials or osmogents were characterized in the simulated gastric fluid (SGF) and pH change medium. Results demonstrated that when propranolol was layered on NP, Eudragit RS plasticized with 30% triethylcitrate (TEC) coated at 15% level could adjust a lag time close to the reference but with a slower release rate after then, while EC plasticized with HPMC could not delay drug release at a lag time close to the reference. Furthermore, EC incorporated with lactose coated on the extrusion-spheronized pellets could adjust the lag time, but a release rate correspondingly decreased with increasing lag time. Nevertheless, coating Eudragit RS on matrix pellets as controlling membrane at different levels could adjust a desired lag time with a pulsatile release pattern. However, the lag time adjusted was only within a 5 h range. Finally, coating Eudragit RS at different level on matrix pellets containing various ratio of osmogent, NaCl or lactose, could effectively adjust a desired lag time as long as 15 h with a pulsatile release pattern to accomplish the timely controlled release with minimization of the pH effects of gastrointestinal tract that could meet the clinical need for chronotherapy of propranolol.

Original languageEnglish
JournalJournal of Food and Drug Analysis
Volume21
Issue number1
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Chronotherapy
propranolol
Propranolol
pellets
extrusion
coatings
lactose
gastrointestinal system
drugs
Lactose
seeds
Gastrointestinal Tract
Seeds
stomach
Membranes
Dosage Forms
dosage
Stomach

Keywords

  • Timely controlled release, lag time, ethylcellulose, eudragit rs, osmogents

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

Cite this

@article{897b6e7f0bf347079cf416f06a37b1b5,
title = "Development of timely controlled-release systems for chronotherapy of propranolol with minimization of the pH effect in the simulated gastrointestinal medium",
abstract = "A timely controlled release dosage form with minimization of transit time and pH effects of gastrointestinal tract for chronotherapy of propranolol was developed. Ethylcellulose (EC) and Eudragit RS selected as the controlling membrane for drug-layering non-pareil seeds (NP) or extrusion-spheronized pellets incorporated with matrix materials or osmogents were characterized in the simulated gastric fluid (SGF) and pH change medium. Results demonstrated that when propranolol was layered on NP, Eudragit RS plasticized with 30{\%} triethylcitrate (TEC) coated at 15{\%} level could adjust a lag time close to the reference but with a slower release rate after then, while EC plasticized with HPMC could not delay drug release at a lag time close to the reference. Furthermore, EC incorporated with lactose coated on the extrusion-spheronized pellets could adjust the lag time, but a release rate correspondingly decreased with increasing lag time. Nevertheless, coating Eudragit RS on matrix pellets as controlling membrane at different levels could adjust a desired lag time with a pulsatile release pattern. However, the lag time adjusted was only within a 5 h range. Finally, coating Eudragit RS at different level on matrix pellets containing various ratio of osmogent, NaCl or lactose, could effectively adjust a desired lag time as long as 15 h with a pulsatile release pattern to accomplish the timely controlled release with minimization of the pH effects of gastrointestinal tract that could meet the clinical need for chronotherapy of propranolol.",
keywords = "Timely controlled release, lag time, ethylcellulose, eudragit rs, osmogents",
author = "Lee, {Lin Wen} and Hung, {Sheng Feng} and Lin, {Hong Liang} and Ho, {Hsiu O.} and Sheu, {Ming Thau}",
year = "2013",
month = "3",
doi = "10.6227/jfda.2013210115",
language = "English",
volume = "21",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Development of timely controlled-release systems for chronotherapy of propranolol with minimization of the pH effect in the simulated gastrointestinal medium

AU - Lee, Lin Wen

AU - Hung, Sheng Feng

AU - Lin, Hong Liang

AU - Ho, Hsiu O.

AU - Sheu, Ming Thau

PY - 2013/3

Y1 - 2013/3

N2 - A timely controlled release dosage form with minimization of transit time and pH effects of gastrointestinal tract for chronotherapy of propranolol was developed. Ethylcellulose (EC) and Eudragit RS selected as the controlling membrane for drug-layering non-pareil seeds (NP) or extrusion-spheronized pellets incorporated with matrix materials or osmogents were characterized in the simulated gastric fluid (SGF) and pH change medium. Results demonstrated that when propranolol was layered on NP, Eudragit RS plasticized with 30% triethylcitrate (TEC) coated at 15% level could adjust a lag time close to the reference but with a slower release rate after then, while EC plasticized with HPMC could not delay drug release at a lag time close to the reference. Furthermore, EC incorporated with lactose coated on the extrusion-spheronized pellets could adjust the lag time, but a release rate correspondingly decreased with increasing lag time. Nevertheless, coating Eudragit RS on matrix pellets as controlling membrane at different levels could adjust a desired lag time with a pulsatile release pattern. However, the lag time adjusted was only within a 5 h range. Finally, coating Eudragit RS at different level on matrix pellets containing various ratio of osmogent, NaCl or lactose, could effectively adjust a desired lag time as long as 15 h with a pulsatile release pattern to accomplish the timely controlled release with minimization of the pH effects of gastrointestinal tract that could meet the clinical need for chronotherapy of propranolol.

AB - A timely controlled release dosage form with minimization of transit time and pH effects of gastrointestinal tract for chronotherapy of propranolol was developed. Ethylcellulose (EC) and Eudragit RS selected as the controlling membrane for drug-layering non-pareil seeds (NP) or extrusion-spheronized pellets incorporated with matrix materials or osmogents were characterized in the simulated gastric fluid (SGF) and pH change medium. Results demonstrated that when propranolol was layered on NP, Eudragit RS plasticized with 30% triethylcitrate (TEC) coated at 15% level could adjust a lag time close to the reference but with a slower release rate after then, while EC plasticized with HPMC could not delay drug release at a lag time close to the reference. Furthermore, EC incorporated with lactose coated on the extrusion-spheronized pellets could adjust the lag time, but a release rate correspondingly decreased with increasing lag time. Nevertheless, coating Eudragit RS on matrix pellets as controlling membrane at different levels could adjust a desired lag time with a pulsatile release pattern. However, the lag time adjusted was only within a 5 h range. Finally, coating Eudragit RS at different level on matrix pellets containing various ratio of osmogent, NaCl or lactose, could effectively adjust a desired lag time as long as 15 h with a pulsatile release pattern to accomplish the timely controlled release with minimization of the pH effects of gastrointestinal tract that could meet the clinical need for chronotherapy of propranolol.

KW - Timely controlled release, lag time, ethylcellulose, eudragit rs, osmogents

UR - http://www.scopus.com/inward/record.url?scp=84877848182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877848182&partnerID=8YFLogxK

U2 - 10.6227/jfda.2013210115

DO - 10.6227/jfda.2013210115

M3 - Article

VL - 21

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 1

ER -